Abstract
Rhokinase inhibitors is a new class of drug under trial that improve the outflow facility through conventional path way by inhibiting the contractile tone of actin cytoskeleton. They additionally protect trabecular meshwork from oxidative stress, improve Optic Nerve head blood flow, facilitate corneal endothelium wound healing, increase ganglion cell survival and reduce scarring in glaucoma surgery.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
